相关实验视频
Updated: Jul 25, 2025
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.5K
阿曼塔丁用于治疗抑郁症-试点案例系列研究
Marek Krzystanek1, Ewa Martyniak1, Artur Pałasz2
1Department and Clinic of Psychiatric Rehabilitation, Faculty of Medical Sciences, Medical University of Silesia in Katowice, 40-635 Katowice, Poland.
Pharmaceuticals (Basel, Switzerland)
|June 28, 2023
概括
阿曼塔丁 (Amantadine) 显示出作为治疗抑郁症的第二线治疗方法的前景,抑郁症是一种慢性情绪障碍. 这项研究发现,阿曼塔丁有效地迅速减少了抑郁症状,并且即使在停止治疗后也能很好地耐受.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抑郁症是一种持续的,慢性情绪障碍,影响日常生活.
- 目前的治疗指南缺乏对初始抗抑郁药疗法没有反应的患者的建议.
- 确定有效的二线治疗方法对于心虚症至关重要.
研究的目的:
- 调查阿曼塔丁作为二线治疗抑郁症的疗效和耐受性.
- 为了在自然主义的案例研究环境中比较阿曼塔丁与塞特拉林的作用.
主要方法:
- 一个开放的,自然主义的案例研究,涉及五名被诊断患有抑郁症和先前抗抑郁药治疗失败的患者.
- 患者接受阿曼塔丁 (100毫克/天) 治疗3个月,随访3-5个月.
- 一个年龄和性别匹配的对照组接受了塞特拉林 (100毫克/天).
- 使用汉密尔顿抑郁评分表 (HDRS-17) 评估抑郁症状.
主要成果:
- 所有接受阿曼塔丁治疗的患者在一个月内显著减少了抑郁症状.
- 在随后的两个月阿曼塔丁治疗期间,症状的改善持续并增加.
- 在对照组中,阿曼塔丁的治疗效果与塞特拉林相当.
- 在停止使用阿曼塔丁后,没有发现任何不良反应或健康状况恶化.
结论:
- 阿曼塔丁是一种潜在的有效和耐受良好的二线选择,用于治疗抑郁症.
- 阿曼塔丁可以提供快速改善症状,并具有持久的治疗效果.
- 需要进一步的研究,以在更大的受控试验中证实这些发现.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
279
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
279
01:27Depressive Disorders: MDD and Dysthymia
176
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
176
01:24Parkinson's Disease: Treatment
303
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
303
01:25Antidepressant Drugs: Overview
600
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
600
01:22Alzheimer's Disease: Treatment
222
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
222
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
453
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
453